Efficacy and Safety of Once Weekly Semaglutide 2.4 mg for Weight Management in East Asian Individuals With Overweight or Obesity
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Efficacy and safety of once weekly semaglutide 2·4 mg for weight management in a predominantly east Asian population with overweight or obesity (STEP 7): a double-blind, multicentre, randomised controlled trial
Lancet Diabetes Endocrinol 2024 Feb 05;[EPub Ahead of Print], Y Mu, X Bao, FG Eliaschewitz, MR Hansen, BT Kim, A Koroleva, RCW Ma, T Yang, N Zu, M LiuFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.